Sath Shukla

Affiliations

  • Ceo & President at Spero Therapeutics Inc. (SPRO), 2025-02-06
  • Evp, Chief Financial Officer at Ziopharm Oncology Inc (ZIOP), 2020-01-31
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SPRO $0.78 106,408 $82,998.24 1,736,883 2025-02-05 Filing
SPRO $0.78 42,786 $33,373.08 1,843,291 2025-02-05 Filing
SPRO $0.78 6,139 $4,788.42 1,886,077 2025-02-05 Filing
SPRO $1.35 2,757 $3,721.95 1,140,809 2024-08-27 Filing
SPRO $1.31 17,641 $23,109.71 1,143,566 2024-08-05 Filing